DAILY TREATMENT WITH THE GLUTAMATE RECEPTOR ANTAGONIST MK-801 RETARDS BEHAVIORAL AND NEUROCHEMICAL RECOVERY FROM PARTIAL 6-HYDROXYDOPAMINE LESIONS OF THE SUBSTANTIA NIGRA

1995 ◽  
Vol 6 (5) ◽  
pp. 621
Author(s):  
A EMMI ◽  
H RAJABI ◽  
J STEWART
Keyword(s):  
Substantia Nigra ◽  
Receptor Antagonist ◽  
Glutamate Receptor ◽  
Daily Treatment ◽  
Glutamate Receptor Antagonist ◽  
Mk 801 ◽  
6 Hydroxydopamine

Chronic treatment with the glutamate receptor antagonist MK-801 alters periodontal disease susceptibility

2005 ◽  
Vol 40 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Torbjorn Breivik ◽  
Yngvar Gundersen ◽  
Harald Osmundsen ◽  
Per Kristian Opstad ◽  
Frode Fonnum
Keyword(s):  
Periodontal Disease ◽  
Receptor Antagonist ◽  
Glutamate Receptor ◽  
Chronic Treatment ◽  
Disease Susceptibility ◽  
Glutamate Receptor Antagonist ◽  
Mk 801

A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria

2016 ◽  
Vol 54 (9) ◽  
pp. 7063-7082 ◽  
Author(s):  
Aline Silva de Miranda ◽  
Fátima Brant ◽  
Luciene Bruno Vieira ◽  
Natália Pessoa Rocha ◽  
Érica Leandro Marciano Vieira ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cerebral Malaria ◽  
Glutamate Receptor ◽  
Neuroprotective Effect ◽  
Behavioral Outcomes ◽  
Glutamate Receptor Antagonist ◽  
Experimental Cerebral Malaria

Structure of kaitocephalin, a novel glutamate receptor antagonist produced by Eupenicillium shearii

1997 ◽  
Vol 38 (40) ◽  
pp. 7079-7082 ◽  
Author(s):  
Kazuo Shin-ya ◽  
Jung-Sik Kim ◽  
Kazuo Furihata ◽  
Yoichi Hayakawa ◽  
Haruo Seto
Keyword(s):  
Receptor Antagonist ◽  
Glutamate Receptor ◽  
Glutamate Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document